Psilocybin
US Congress Adds Psychedelics Studies to Defense Bill
A bipartisan group of congressional lawmakers from both the House and the Senate have added funding for studies of psychedelic therapies into a major defense…
The psychedelic renaissance continues to gain legitimacy, supported by the most unlikely of allies — the United States military.
This week a bipartisan group of congressional lawmakers from both the House and the Senate have agreed to add funding for studies of psychedelic therapies into a major defense bill.
The 2024 National Defense Authorization Act (NDAA) passed on Wednesday and included the provision for psychedelics research introduced by Republican lawmakers like Rep. Morgan Luttrell of Texas.
The bill’s psychedelic sections require the Department of Defense (DOD) to facilitate access for military veterans to clinical trials for the treatment of PTSD or traumatic brain injury. The provisions allow for participating in studies using psilocybin, MDMA, ibogaine and 5-MeO-DMT (and “qualified plant-based alternative therapies”).
This isn’t a suggestion but a requirement, one that forces the Department of Defense to facilitate access for military service members, in addition to providing $10 million in funding, and partnerships with agencies and academic institutions doing psychedelic research.
Another major step forward for institutional acceptance of psychedelic therapies.
The times they are indeed a changing
For more on military support of psychedelics, check out Republican Lawmakers Introduce New Bill for Psychedelic Therapy
The post US Congress Adds Psychedelics Studies to Defense Bill appeared first on Microdose.
ibogaine psilocybin mdma dmt psychedelic psychedelic research therapy ptsd psychedelics funding authorization research-
Psilocybin1 week ago
Are Shrooms Legal in Oregon: Full Guide
-
Psychedelics1 week ago
Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
-
Law & Regulation1 week ago
Clearmind signs agreement with Hebrew University for psychedelic compound rights
-
Psychedelics1 week ago
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
-
Psilocybin1 week ago
California advances bill for psychedelics centers
-
Psilocybin4 days ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
Psychedelics Can Offer More Than Therapy On Its Own
-
Psychedelics1 week ago
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product